Bhubaneswar: Ace Odisha sprinter Dutee Chand’s career is under eclipse again with the International Association of Athletics Federations (IAAF) mulling to move Court of Arbitration for Sport (CAS) in Switzerland.
In its interim order ruling in July 2015, the CAS panel had suspended the IAAF Regulation Governing Eligibility of Females with Hyperandrogenism to Compete in Women’s Competition (the “Hyperandrogenism Regulations”) for a maximum period of two years in order to give the IAAF the opportunity to provide the CAS with scientific evidence about the quantitative relationship between enhanced testosterone levels and improved athletic performance in hyperandrogenic athletes.
Following the interim order, CAS had allowed Dutee to compete in all international events for the next two years.
“Funded by the IAAF and the World Anti-Doping Agency, the study describes and characterises serum androgen levels and studies their possible influence on athletic performance in both male and female elite athletes. The study analysed 2127 mass spectrometry-measured serum androgen concentrations obtained from elite athletes participating in the 2011 and 2013 IAAF World Championships,” the IAAF said in the release.
In addition to this, the study found that in certain events female athletes with high testosterone levels benefit from a 1.8% to 4.5% competitive advantage over female athletes with lower testosterone levels.
“The article ‘Serum androgen levels and their relation to performance in track and field: mass spectrometry results from 2127 observations in male and female elite athletes’ is part of the evidence that the IAAF is preparing for its return to CAS. The authors, Drs Stephane Bermon and Pierre-Yves Garnier, submitted the study for scientific peer review, and the article and related research has now been published in the British Journal of Sports Medicine,” it further said.
This comes a day before the 21-year-old athlete is to participate in the Asian Athletics Championships held in Bhubaneswar.